Today
-1.83%
5 Days
-5.22%
1 Month
+11.25%
6 Months
+3.02%
Year to Date
+17.90%
1 Year
+19.42%
• EMR stock declined due to market sentiment, analyst actions, and macro concerns. • Company reported strong Q1 2026 earnings, beating EPS and matching revenue. • Analysts downgraded EMR, citing overvalued industrials and geopolitical risks.
• Emerson Electric reported strong Q1 2026 earnings exceeding expectations. • Full-year 2026 EPS guidance was raised due to robust order growth. • The company remains a "Buy" rating with raised price targets.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.52% |
| State Street Investment Management (US) | 4.91% |
| BlackRock Institutional Trust Company, N.A. | 4.68% |
| JP Morgan Asset Management | 2.68% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 43.78% |
| Investment Advisor/Hedge Fund | 25.64% |
| Research Firm | 5.48% |
| Bank and Trust | 4.22% |
Related Instruments
Popular Instruments